Abstract
Introduction: A muscle loss is associated with a symptomatic Coronavirus disease 2019 (COVID-19) by histologic and body compositions and biochemical analysis in quantification measures. Is unclear the mechanism for muscle damage in these patients, but the tomographic measurement is a result that appears in the analyses in hospitalized patients. Objective: The aim of this study is to evaluate the influence of COVID-19 on weight loss, cachexia and sarcopenia. Methods: The literature review was conducted according to the SANRA Statement utilizing PubMed, Lilacs, Google Scholar and Cochrane Library databases. First, to identify relevant publications about COVID-19 and muscle and weight loss, the combined search terms were used: (1) COVID-19 OR SARS-CoV-2 (2) cachexia OR muscle wasting and (3) exercise OR nutrition. Results and conclusions: Previous information related the cytokines, nutrition, pharmacological treatment, physical inactivity during intensive care unit (ICU) stays, mechanical ventilation are associated with de sarcopenia and cachexia in COVID-19 patients. In studies area association between imaging and physical test performance, anthropometric measures and muscle dystrophy blood marks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
